Clinical and epidemiological features of patients with genitourinary tract tumour in a blackfoot disease endemic area of Taiwan

BJU International

Volumn 102, Issue 1, 2008, Pages 48-54

  Tan, Lia Beng ^a,b   Chen, Kow Tong ^a   Guo, How Ran ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b God's Help Hospital   (Taiwan)

Author keywords

Blackfoot disease; Clinicopathological features; Genitourinary tract; Prognosis; Transitional cell carcinoma

Indexed keywords

ARSENIC;

ADULT; AGE DISTRIBUTION; AGED; ARSENIC POISONING; ARTICLE; BLACKFOOT DISEASE; CANCER GRADING; CANCER MORTALITY; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; DATA BASE; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRIORITY JOURNAL; PROGNOSIS; SEX RATIO; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; TAIWAN; TRANSITIONAL CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMOR GROWTH; UROGENITAL TRACT CANCER;

ADULT; AGED; AGED, 80 AND OVER; ARSENIC POISONING; CARCINOMA, TRANSITIONAL CELL; ENDEMIC DISEASES; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; TAIWAN; UROGENITAL NEOPLASMS; WATER SUPPLY;

EID: 44849087013     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07565.x     Document Type: Article

References (40)

1. Guo HR. Arsenic level in drinking water and mortality of lung cancer (Taiwan). Cancer Causes Control 2004 15 : 171 7
2. Guha Mazumder DN, Haque R, Ghosh N et al. Arsenic levels in drinking water and the prevalence of skin lesions in West Bengal. India Int J Epidemiol 1998 27 : 871 7
3. Chen KP, Wu HY. Epidemiologic studies on blackfoot disease in Taiwan. J Formosan Med Assoc 1965 64 : 456 69
4. Chen CJ, Wang CJ. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 1990 50 : 5470 4
5. Chiou HY, Chiou ST, Hsu YH et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow up of 8102 residents in an arseniasis endemic area in northestern Taiwan. Am J Epidemiol 2001 153 : 411 8
6. Chen CJ, Chuang YC, Yon SL, Lin TM, Wu HY. A retrospective study on malignant neoplasms of bladder, lung, and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 1986 53 : 399 405
7. Liaw KF, Horng SF, Lin LJ et al. A cohort study on lower urinary tract cancers in the endemic area of blackfoot disease. Chin J Public Health (Taipei) 1995 14 : 23 31
8. Chen CJ, Wu MM, Le SS, Wang JD, Cheng SH, Wu HY. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Artheriosclerosis 1988 8 : 452 60
9. Chen CJ, Chuang YC, Lin TM, Wu HY. Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan: high-arsenic artesian well water and cancers. Cancer Res 1985 45 : 5895 9
10. Mostofi FK, Sobin LH, Torloni H. Histologic typing of urinary bladders. In Mostofi FK International Histological Classification of Tumors. Geneva : WHO, 1973 : 21 31
11. American Joint Committee on Cancer. AJCC Cancer Staging Handbook, 5th edn. Philadelphia : Lippincott-Raven Publishers, 1998
12. Babaian R, Johnson DE. Primary carcinoma of the ureter. J Urol 1980 123 : 357 9
13. Petkovic SD. Epidemiologic and treatment of renal pelvic and ureter tumors. J Urol 1975 114 : 858 65
14. Anderstrom C, Johansson SL, Petterson S, Wahlqvist L. Carcinoma of the ureter: a clinicopathologic study of 49 cases. J Urol 1989 142 : 280 3
15. Mellemgaard A, Carstensen B, Norgaard N, Knudsen JB, Olsen JH. Trends in the incidence of cancer of the kidney, pelvis, ureter and bladder in Denmark 1943-88. Scand J Urol Nephrol 1993 27 : 327 32
16. Munoz JJ, Ellison LM. Upper tract urothelial neoplasms. Incidence and survival during the last 2 decades. J Urol 2000 164 : 1523 5
17. McCarron JP, Vaughn ED Jr. Tumors of the renal pelvis and ureter: current concepts and management. Semin Urol 1983 1 : 75 81
18. Ozsahin M, Zouhair A, Villa S et al. Prognostic factors in urothelial renal pelvic and ureter tumors: a multicentre rare cancer network study. Eur J Cancer 1999 35 : 738 43
19. Huben RP, Mounzer AM, Murphy GP. Tumor grade and stage as prognostic variables in upper tract urothelial tumors. Cancer 1988 62 : 2016 20
20. Tawfiek ER, Bagley DH. Upper-tract transitional cell carcinoma. Urology 1997 50 : 321 9
21. Yang MH, Chen KK, Yen CC et al. Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan. Urology 2002 59 : 681 7
22. Guo HR, Chiang HS, Hu H, Lipsitz SR, Monson RR. Arsenic in drinking water and incidence of urinary cancers. Epidermiology 1997 8 : 545 50
23. Hsieh YF, Ling GC, Lu YB. Incidence of tumor of the renal pelvic in Taiwan. Taiwan Yi Xue Hui Za Zhi 1979 78 : 749 53
24. Chou YH, Huang CH. Unusual clinical presentation of upper urothelial cancer in Taiwan. Cancer 1999 85 : 1342 4
25. Lytton B. Primary cancer of the ureter. A report of 102 cases. J Urol 1970 103 : 590 8
26. Petkovic SD. Conservation of the kidney in operations for tumours of the renal pelvis and calyces. Br J Urol 1972 44 : 1 8
27. Murphy DM, Zinke H, Furlow WL. Primary grade 1 transitional cell carcinoma of the renal pelvis and ureter. J Urol 1980 123 : 692 4
28. Geol MC, Mahendra V, Roberts JG. Percutaneous management of renal pelvic urothelial tumors: long-term followup. J Urol 2003 169 : 925 30
29. Park S, Hong B, Kim CS, Ahn H. The impact of tumor location on prognosis of transitional cell carcinoma of the upper urinary tract. J Urol 2004 171 : 621 5
30. Heney NM, Nocks BN, Daly JJ, Blitzer PH, Parkhurst EC. Prognostic factors in carcinoma of the ureter. J Urol 1981 125 : 632 6
31. Lu FJ, Liu TM. Fluorescent-compounds in drinking water of blackfoot disease endemic areas: animal experiments model. J Formosan Med Assoc 1986 85 : 352 8
32. Lu JN, Chen CJ. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res 1991 11 : 229 34
33. Lee TC, Oshimura M, Barrett JC. Comparison of arsenic-induced cell transformation, cytotoxicity, mutation and cytogenetic effect in Syrian hamster embryo cells in culture. Carcinogenesis 1985 6 : 1421 6
34. Lee TC, Tanka N, Lamb PW, Gilmer TM, Barrete JC. Induction of gene amplification by arsenic. Science 1988 241 : 79 81
35. Vahter M, Marafante E. Intracellular interaction and metabolic fate of arsenic and arsenate in mice and rabbits. Chem Biol Interact 1983 47 : 29 44
36. Vahter M, Marafante E. Effects of low dietary intake of methionine, choline or proteins on the biotransformation of arsenite in the rabbit. Toxicol Lett 1987 37 : 41 6
37. Hsueh YM, Cheng GS, Wu MM, Yu HS, Kuo TL, Chen CJ. Multiple risk factors associated with arsenic-induced skin cancer: effects of chronic liver and malnutritional status. Br J Cancer 1995 71 : 109 14
38. Thompson DJ. A chemical hypothesis for Arsenic methylation in mammals. Chem Biol Interact 1993 88 : 89 114
39. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health 1981 48 : 111 8
40. Ivankovic S, Eisenbrand G, Preussman R. Lung carcinoma induction in BD rats after a single intratracheal instillation of an arsenic-containing pesticide mixture formerly used in vineyards. Int J Cancer 1979 24 : 786 8